Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Acad Radiol. 2011 Nov 21;19(2):184–190. doi: 10.1016/j.acra.2011.10.008

Figure 2.

Figure 2

SUV sensitivity to change in FDG uptake measured by FDG flux (Ki) in a cohort of 75 locally advanced breast cancer patients undergoing neoadjuvant chemotherapy, by tertiles of baseline SUV. For a change in Ki of −100%, (A) the predicted percent change in SUV is −52% for the first tertile (baseline SUV ≤ 3), (B) −71% for the second tertile (3 ≤ baseline SUV ≤ 5.2), and (C) −88% for the third tertile (baseline SUV > 5.2).